利索-全球专利检索

  1. 登录
  2. 注册
发明公开
CN110772607A 一种改善糖尿病肾病的中药组合物及其制剂 无效 - 驳回

一种改善糖尿病肾病的中药组合物及其制剂
摘要：
本发明公开了一种改善糖尿病肾病的中药组合物，包括以下重量份的原料药物：黄芪25～35份、杜仲10～20份、玉米须25～35份、黄连5～15份和丹参25～35份，以及萹蓄、沙苑子和茵陈，其中，萹蓄15～25份、沙苑子15～25份、茵陈25～35份。所述改善糖尿病肾病的中药组合物合现代系统药理学的理论，所选药物能糖尿病肾病的疾病靶点；同时又符合传统的中医辨证理论体系，诸药合用可有效针对糖尿病肾病的病理特点，相对其他现有的复方中药，具有药味较少、疗效确定可靠、主要药性成分明确的优点，可以减少中药复方制剂中的非药效因素，提高制剂水平。
摘要（英）：

The invention discloses a traditional Chinese medicine composition for relieving diabetic nephropathy. The traditional Chinese medicine composition is prepared from the following medicinal raw materials in parts by weight: 25 to 35 parts of radix astragali, 10 to 20 parts of cortex eucommiae, 25 to 35 parts of corn stigma, 5 to 15 parts of rhizoma coptidis, 25 to 35 parts of radix salviae miltiorrhizae, 15 to 25 parts of herba polygoni avicularis, 15 to 25 parts of semen astragali complanati and 25 to 35 parts of herba artemisiae scopariae. The traditional Chinese medicine composition for relieving diabetic nephropathy is combined with the theory of modern systematic pharmacology, and the selected medicines can target disease targets of diabetic nephropathy; and meanwhile, the traditionalChinese medicine composition conforms to a traditional Chinese medicine differentiation theoretical system, the medicines are combined to effectively aim at pathological characteristics of diabetic nephropathy, and compared with other existing compound traditional Chinese medicines, the traditional Chinese medicine composition has the advantages of few medicines, definite and reliable curative effect and clear main medicinal components, non-pharmacodynamic factors in a traditional Chinese medicine compound preparation can be reduced, and the preparation level is improved.

0/0